NCT05947565

Brief Summary

The goal of this study is to learn whether the change or patient position might effect the results of invasive urodynamic study in males.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 17, 2023

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

July 9, 2023

Last Update Submit

July 9, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Invasive urodynamic study

    Sitting position

    1 day

  • Invasive urodynamic study

    Standing position

    1 day

Study Arms (2)

Group 1

ACTIVE COMPARATOR

Invasive urodynamic study will be performed firstly in sitting position. Then, repeated in standing position.

Diagnostic Test: Invasive Urodynamic Study

Group 2

ACTIVE COMPARATOR

Invasive urodynamic study will be performed firstly in standing position. Then, repeated in sitting position.

Diagnostic Test: Invasive Urodynamic Study

Interventions

Invasive Urodynamic Study (Filling cystometry and pressure-flow study) Under sterile conditions and at lithotomy position, an urethral and a rectal catheter will be inserted. Bladder will be filled by sterile saline slowly. The first feeling of urine, the first sensation of urination and the sensation of severe desire to urinate will be recorded step by step. Vesical, rectal and detrusor pressures will be monitorized during these period. After the strong desire to void sensation, filling cystometry phase will be completed. Sterile saline infusion is stopped. While the patient urinates the vesical, detrusor and rectal pressures, the maximum and average urine flow rates will be recorded.

Group 1Group 2

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMales over 18 years old and capable of standing during test
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males over 18 years old and capable of standing during test

You may not qualify if:

  • Patients not able to stand up during the test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lower Urinary Tract SymptomsDisease

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Central Study Contacts

Tufan Tarcan, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 9, 2023

First Posted

July 17, 2023

Study Start

October 1, 2023

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

July 17, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share